Oaktree Acquisition Corp. II
Completed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $225M
- Underwriters
- Focus
- Industrial, Consumer
- SEC Filings
- 1820931
- Public Embarc Page
- https://embarc.com/capital/spac/1820931/OACB/oaktree-acquisition
- IPO Ticker
- OACB
SPAC Leadership
Information on the SPAC leadership.
- Chief Executive Officer and DirectorPatrick McCaney
- PresidentAlexander Taubman
- Chief Financial Officer and Head of M&AZaid Pardesi
- Chief Operating OfficerMathew Pendo
- Chairman and DirectorJohn Frank
- DirectorPaul Meister(Former Exec Vice Chairman, Revlon, Chairman Thermo Fisher)
- DirectorAndrea Wong
- DirectorAnthony Grillo
Target Information
Information on the SPAC target for merger.
- Company
- Alvotech
- Presentation
- Investor Presentation (SEC) on 2022-02-16
- Description
- Alvotech is "a leading pure play biosimilar platform focused on the development and manufacture of high-quality biosimilar medicines for global markets."